407 related articles for article (PubMed ID: 17457163)
1. Long-term outcomes following neoadjuvant chemoradiotherapy for esophageal cancer.
Reynolds JV; Muldoon C; Hollywood D; Ravi N; Rowley S; O'Byrne K; Kennedy J; Murphy TJ
Ann Surg; 2007 May; 245(5):707-16. PubMed ID: 17457163
[TBL] [Abstract][Full Text] [Related]
2. Initial stage affects survival even after complete pathologic remission is achieved in locally advanced esophageal cancer: analysis of 70 patients with pathologic major response after preoperative chemoradiotherapy.
Kim MK; Cho KJ; Park SI; Kim YH; Kim JH; Song HY; Shin JH; Jung HY; Lee GH; Choi KD; Song HJ; Ryu JS; Kim SB
Int J Radiat Oncol Biol Phys; 2009 Sep; 75(1):115-21. PubMed ID: 19251379
[TBL] [Abstract][Full Text] [Related]
3. Retrospective review of patients with locally advanced esophageal cancer treated at the University of Pittsburgh.
Defoe SG; Pennathur A; Flickinger JC; Heron DE; Gibson MK; Luketich JD; Greenberger JS
Am J Clin Oncol; 2011 Dec; 34(6):587-92. PubMed ID: 22101387
[TBL] [Abstract][Full Text] [Related]
4. Lymph node dissection after chemoradiation in esophageal cancer: a subgroup analysis of patients with and without pathological response.
Chao YK; Liu HP; Hsieh MJ; Wu YC; Liu YH; Yeh CH; Chang HK; Tseng CK
Ann Surg Oncol; 2012 Oct; 19(11):3500-5. PubMed ID: 22622470
[TBL] [Abstract][Full Text] [Related]
5. Histomorphologic tumor regression and lymph node metastases determine prognosis following neoadjuvant radiochemotherapy for esophageal cancer: implications for response classification.
Schneider PM; Baldus SE; Metzger R; Kocher M; Bongartz R; Bollschweiler E; Schaefer H; Thiele J; Dienes HP; Mueller RP; Hoelscher AH
Ann Surg; 2005 Nov; 242(5):684-92. PubMed ID: 16244542
[TBL] [Abstract][Full Text] [Related]
6. Pathologic T0N1 esophageal cancer after neoadjuvant therapy and surgery: an orphan status.
Kim MP; Correa AM; Lee J; Rice DC; Roth JA; Mehran RJ; Walsh GL; Ajani JA; Maru DM; Chang JY; Marom EM; Macapinlac HA; Lee JH; Vaporciyan AA; Rice T; Swisher SG; Hofstetter WL
Ann Thorac Surg; 2010 Sep; 90(3):884-90; discussion 890-1. PubMed ID: 20732513
[TBL] [Abstract][Full Text] [Related]
7. Squamous cell carcinoma of the esophagus: multimodal therapy in locally advanced disease.
El Nakadi I; Van Laethem JL; Houben JJ; Gay F; Closset J; Van Houtte P; Danhier S; Limbosch JM; Lambilliotte JP; Gelin M
World J Surg; 2002 Jan; 26(1):72-8. PubMed ID: 11898037
[TBL] [Abstract][Full Text] [Related]
8. Worldwide Oesophageal Cancer Collaboration guidelines for lymphadenectomy predict survival following neoadjuvant therapy.
Stiles BM; Nasar A; Mirza FA; Lee PC; Paul S; Port JL; Altorki NK
Eur J Cardiothorac Surg; 2012 Oct; 42(4):659-64. PubMed ID: 22491667
[TBL] [Abstract][Full Text] [Related]
9. High cyclooxygenase-2 expression following neoadjuvant radiochemotherapy is associated with minor histopathologic response and poor prognosis in esophageal cancer.
Xi H; Baldus SE; Warnecke-Eberz U; Brabender J; Neiss S; Metzger R; Ling FC; Dienes HP; Bollschweiler E; Moenig S; Mueller RP; Hoelscher AH; Schneider PM
Clin Cancer Res; 2005 Dec; 11(23):8341-7. PubMed ID: 16322294
[TBL] [Abstract][Full Text] [Related]
10. Survival effect of neoadjuvant radiotherapy before esophagectomy for patients with esophageal cancer: a surveillance, epidemiology, and end-results study.
Schwer AL; Ballonoff A; McCammon R; Rusthoven K; D'Agostino RB; Schefter TE
Int J Radiat Oncol Biol Phys; 2009 Feb; 73(2):449-55. PubMed ID: 18538500
[TBL] [Abstract][Full Text] [Related]
11. Retrospective analysis of outcome differences in preoperative concurrent chemoradiation with or without elective nodal irradiation for esophageal squamous cell carcinoma.
Hsu FM; Lee JM; Huang PM; Lin CC; Hsu CH; Tsai YC; Lee YC; Chia-Hsien Cheng J
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e593-9. PubMed ID: 21658851
[TBL] [Abstract][Full Text] [Related]
12. Distant nodal metastases from intrathoracic esophageal squamous cell carcinoma: characteristics of long-term survivors after chemoradiotherapy.
Chao YK; Wu YC; Liu YH; Tseng CK; Chang HK; Hsieh MJ; Chu Y; Liu HP
J Surg Oncol; 2010 Aug; 102(2):158-62. PubMed ID: 20648587
[TBL] [Abstract][Full Text] [Related]
13. The clinical impact of histopathologic response assessment by residual tumor cell quantification in esophageal squamous cell carcinomas.
Brücher BL; Becker K; Lordick F; Fink U; Sarbia M; Stein H; Busch R; Zimmermann F; Molls M; Höfler H; Siewert JR
Cancer; 2006 May; 106(10):2119-27. PubMed ID: 16607651
[TBL] [Abstract][Full Text] [Related]
14. Prediction of prognosis after trimodal therapy in patients with locally advanced squamous cell carcinoma of the oesophagus.
Stahl M; Lehmann N; Walz MK; Stuschke M; Wilke H
Eur J Cancer; 2012 Nov; 48(16):2977-82. PubMed ID: 22503151
[TBL] [Abstract][Full Text] [Related]
15. A reliable risk score for stage IV esophagogastric cancer.
Blank S; Lordick F; Dobritz M; Grenacher L; Burian M; Langer R; Roth W; Schaible A; Becker K; Bläker H; Sisic L; Stange A; Compani P; Schulze-Bergkamen H; Jäger D; Büchler M; Siewert JR; Ott K
Eur J Surg Oncol; 2013 Aug; 39(8):823-30. PubMed ID: 23375470
[TBL] [Abstract][Full Text] [Related]
16. The prognostic value of residual nodal disease following neoadjuvant chemoradiation for esophageal cancer in patients with complete primary tumor response.
Blackham AU; Yue B; Almhanna K; Saeed N; Fontaine JP; Hoffe S; Shridhar R; Frakes J; Coppola D; Pimiento JM
J Surg Oncol; 2015 Nov; 112(6):597-602. PubMed ID: 26394724
[TBL] [Abstract][Full Text] [Related]
17. Phosphorylated mammalian target of rapamycin expression is associated with the response to chemoradiotherapy in patients with esophageal squamous cell carcinoma.
Li SH; Huang EY; Lu HI; Huang WT; Yen CC; Huang WC; Chen CH
J Thorac Cardiovasc Surg; 2012 Dec; 144(6):1352-9, 1359.e1. PubMed ID: 22841170
[TBL] [Abstract][Full Text] [Related]
18. Predictors of long-term survival after resection of esophageal carcinoma with nonregional nodal metastases.
Lee PC; Port JL; Paul S; Stiles BM; Altorki NK
Ann Thorac Surg; 2009 Jul; 88(1):186-92; discussion 192-3. PubMed ID: 19559222
[TBL] [Abstract][Full Text] [Related]
19. Improved outcomes in the management of esophageal cancer with the addition of surgical resection to chemoradiation therapy.
McKenzie S; Mailey B; Artinyan A; Metchikian M; Shibata S; Kernstine K; Kim J
Ann Surg Oncol; 2011 Feb; 18(2):551-8. PubMed ID: 20839062
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of age in the radical treatment of oesophageal cancer with surgery or chemoradiotherapy: a prospective observational cohort study.
Davies L; Lewis WG; Arnold DT; Escofet X; Blackshaw G; Gwynne S; Evans M; Roberts SA; Appadurai I; Crosby TD
Clin Oncol (R Coll Radiol); 2010 Sep; 22(7):578-85. PubMed ID: 20591633
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
